The present disclosure generally relates to illness detection and more specifically to mass spectrometer techniques for mass detection of viruses and other illness causing molecules.
While many infectious diseases and viruses are known and treatable, the recent outbreak of the COVID-19 virus pandemic has brought to light some of the shortcomings in rapid detection and screening instrumentation. These shortcomings include insufficient resources to diagnose all individuals that are at risk of infection, as well as the absence of a rapid non-invasive diagnosis method. Current diagnosis protocols involve blood withdrawal, swabs, or other highly invasive techniques and extended waiting periods may be needed to obtain the test results. The current diagnosis protocols and the extended waiting periods for obtaining results make it difficult to test large groups of individuals, which can lead to the spread of the infectious disease, wasted treatment efforts (e.g., if some form of treatment is started as a precaution before test results come back and the person is not infected), or increase the severity of the symptoms of infected persons (e.g., because the illness may become more severe while waiting on the test results to confirm the illness before beginning treatment).
The present application is directed to systems, methods, apparatuses and computer-readable storage media facilitating rapid detection and monitoring for the presence of viruses and other infectious diseases. Embodiments may utilize a fan to direct a flow of air in an ambient environment to an inlet of an analysis device. The analysis device may include a heating element downstream of the inlet to heat the ambient air flow, causing resorption of the volatile organic compounds (VOCs) present in the heated air flow. The VOCs may be provided to one or more membrane inlets of the analysis device where the VOCs may be analyzed using a mass spectrometer. The presence of one or more particular VOCs may indicate a virus or infection disease is present in the air flow.
Detection of such viruses and other harmful molecules in accordance with embodiments may be used to perform rapid testing and monitoring of large groups of persons. For example, the analysis device may be set up at the entrance to a building or other public or common area (e.g., a hallway, stairwell, elevator, parking structure, subway terminal, or other types of structures). As people enter or exit the space VOCs may be exhaled as the people breath and the fan may be configured to direct air flows containing the VOCs to the inlet for analysis. If any of the analyzed VOCs signify the presence of a virus or other type of infectious disease or harmful molecules, one or more alerts may be generated to notify one or more individuals of the presence of harmful molecules in the structure. The alerts or notifications may be used to track the spread of a virus, such as COVID-19, and identify large groups of people that may have been exposed to the virus or some other contagion, which may help mitigate the spread of the virus or contagion.
The foregoing has outlined rather broadly the features and technical advantages of the present invention in order that the detailed description of the invention that follows may be better understood. Additional features and advantages of the invention will be described hereinafter which form the subject of the claims of the invention. It should be appreciated by those skilled in the art that the conception and specific embodiment disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims. The novel features which are believed to be characteristic of the invention, both as to its organization and method of operation, together with further objects and advantages will be better understood from the following description when considered in connection with the accompanying figures. It is to be expressly understood, however, that each of the figures is provided for the purpose of illustration and description only and is not intended as a definition of the limits of the present invention.
For a more complete understanding of the present invention, reference is now made to the following descriptions taken in conjunction with the accompanying drawings, in which:
Various features and advantageous details are explained more fully with reference to the non-limiting embodiments that are illustrated in the accompanying drawings and detailed in the following description. Descriptions of well-known starting materials, processing techniques, components, and equipment are omitted so as not to unnecessarily obscure the invention in detail. It should be understood, however, that the detailed description and the specific examples, while indicating embodiments of the invention, are given by way of illustration only, and not by way of limitation. Various substitutions, modifications, additions, and/or rearrangements within the spirit and/or scope of the underlying inventive concept will become apparent to those skilled in the art from this disclosure.
Referring to
For example, in the case of Influenza A the concentration of some VOCs, such as n-propyl acetate, propanal, and acetaldehyde are found to be rather high in a specimen's breath, which may be dispersed in an ambient environment and captured using a fan that directs a flow of air from the ambient environment to an analysis device as described herein. Hemagglutinin is the surface antigen expressed by influenza A, which will bind at the cell surface level to sialic acid, as illustrated in
The unique characteristics of certain VOCs or a combination of VOCs associated with a viral infection may enable rapid detection of viruses, such as COVID-19, through unique VOC signatures that can be used to confirm the presence of viral infections (e.g., COVID-19) in humans that may be detected using a mass spectrometer. The detection of one or more VOCs or combinations of VOCs may enable the system 100 to detect viral infections in via a non-invasive and destruction-free process. Additionally, the system 100 may enable biomarker characterization of viral infections, which would facilitate both the diagnosis and monitoring processes.
As shown in
The I/O devices 124 may include switches, buttons, lights, display devices, or other control elements configured to receive inputs and/or provide outputs in connection with operation of the system 100. For example, switches and/or buttons may be provided to power the system 100 on and off, identify one or more target VOCs to be identified, or other functionality and control features. Lights may be provided to indicate: the system 100 is powered on or off, the identified VOCs (e.g., different lights may be associated with different VOCs that may be identified by the system 100), or to provide other information associated with operation of the system 100. One or more display devices may additionally be provided to display information, such as to indicate the identified VOCs, indicate an operational state of the system 100 (e.g., provide information indicating one or more of the different features described above with respect to the lights or other status information), and the like.
As shown in
The one or more membrane inlets 116 may be configured to allow different VOCs to pass through while excluding other VOCs from passing through. For example, membrane inlets 116 may be configured to allow VOCs of interest to be provided for analysis by analysis device 110 while VOCs that are not of interest may not pass through or be analyzed. It is noted that VOCs of interest may include VOCs that indicate the presence of a virus or other type of infectious disease. While the fan 106 may direct an air flow from the ambient environment towards the inlet 112, the sampling pump may be configured to draw the air flow 102 into the analysis device 120 under controlled conditions. For example, the sampling pump 118 may regulate the flow across the one or more membranes 116 or other chemical capture medium(s), which may prevent over-pressuring the system and under sampling of the surrounding environment. The VOCs of interest may be provided to the analysis components 140 of the analysis device 110. Exemplary operations of the analysis components 140 are described in more detail below.
The fan 106 may be configured to direct the flow of ambient air 102 towards the inlet 112. The fan 106 may be an electric fan powered by a motor. It is noted that
Additionally, it is noted that
The analysis components 140 may include an ionizer 142, a mass analyzer 144, and a detector 146. As described above, the heated air flow may be provided to the one or more membrane inlets 116, which allow the VOCs of interest to pass through the membrane inlet(s) 116. Once the VOCs pass through the membrane inlet(s) 116, they may be provided to the ionizer 142, which may be configured to ionize at least a portion of the VOCs of interest to produce one or more ionized fragments. The mass analyzer 144 may be configured to separate the one or more ionized fragments (e.g., according to a mass-to-charge ratio of the one or more ionized fragments) and the detector 146 may be configured to identify the one or more target VOCs based on the separated one or more ionized fragments. The analysis components 140 may operate under control of, or in coordination with, the one or more processors 122 of the analysis device 110. In an aspect, the analysis components 140 may include a mass spectrometer or a tetrahertz (THz) spectrometer configured to identify the one or more target VOCs present in the ambient air flow 102.
Information associated with one or more VOCs identified in the air flow 102 may be presented to a user or provided to another destination (e.g., a database stored at memory 130). For example, the information associated with the one or more VOCs may be displayed at a display device of the I/O devices 124, incorporated into a message transmitted to the user (e.g., e-mail, short messaging service (SMS), multimedia messaging service (MMS), etc.), an audio alert, a visual alert (e.g., a blinking light(s)), or other type of message or notification configured to provide information to a user about identified VOCs. In an aspect, the memory 130 may include a database that stores information regarding VOC signatures that may identify a single VOC or a combination of VOCs that, when present in the ambient air sample provided by the fan 106, indicate the presence of a virus or other harmful molecule. The VOC signatures may be generated by capturing samples of breath from persons known to be infected by a virus or other infectious disease and identifying correlations between the VOCs present in the persons' breath and the known illness. The VOC signatures may be stored in a database stored at memory 130 and used to detect the presence of the corresponding viruses by the analysis device 110. It is noted that the VOC signatures may include VOCs that may be by-product organic molecules or small molecule metabolites that occur as an artifact of cellular breakdown due to the presence of a virus or other harmful molecule(s).
The system 100 may enable rapid detection of the presence of VOCs correlated to virus infections or other contagions and harmful molecules. For example, results of an analysis cycle may be provided in real-time or near real-time, which may include providing results within a threshold time following introduction of the ambient air to the inlet by the fan. In an aspect, the threshold time may be a real-time threshold in which results are provided within 7 seconds (e.g., 1 second, 2-3 seconds, 4-5 seconds, or 6-7 seconds) of introducing the air flow into the inlet. In some aspects, the threshold time may be longer than 7 seconds (e.g., a near real-time threshold), such as 8-10 seconds, 11-20 seconds, 21-40 seconds, 41-60 seconds, or a time threshold on the order of 1-5 minutes The system 100 may enable large scale testing for the presence of a virus or other infectious disease-causing molecules in a non-invasive and cost efficient manner.
It is noted that while
Having described in some detail the system 100 and how its various components may be used to identify VOCs of interest (e.g., VOCs indicative of a viral infection or other infection disease or illness), exemplary details of experiments demonstrating successful identification of VOCs of interest using the techniques described herein shall be described. Experiments have shown that mass spectrometers could be used to detect a person's metabolic state using the breathalyzer mass spectrometer. Healthy breath samples, breath samples from a person suffering from seasonal allergies (allergy breath), and breath samples from a person directly after washing their mouth out with Listerine were collected using a similar breathalyzer tube with a pre-concentrator attached to a PolarisQ ion trap mass spectrometer. Results of the experiments are shown in
Other breath VOC metabolites have also been found in previously collected breath samples using a similar breathalyzer inlet, as shown in
To determine viral infection of a person in the field, a rapid portable mass spectrometer, such as the system 100 of
Referring to
A mass spectrometer-based system according to the present disclosure, such as the system 100 of
To illustrate, suppose that between the hours of 9:00 AM and 11:00 AM the analysis device 120 does not detect the presence of any VOCs of interest as people enter and exit the building 600, but at 11:05 AM a VOC indicating a virus is detected. As described above, an alert may be generated and personnel may be notified that a person has entered building 600 while suffering from a viral infection. Depending on the particular virus identified, the notified personnel may then take action to prevent further individuals from entering the building (e.g., to prevent additional persons from coming into contact with the detected virus) and to identify persons that are in the building (e.g., to facilitate monitoring of those individuals for signs that they have become infected by the detected virus).
As the COVID-19 pandemic has proven, one of the difficulties in containing a virus can be the containment and mitigation of the spread of the virus. This is because many people may be asymptomatic, causing them to believe they are not suffering from the virus, but those people may be spreading the virus to others who develop more serious and even life threatening symptoms. Despite not showing physical symptoms, such as a cough, a fever, etc., asymptomatic persons may still have VOCs indicative of the virus in their breath, which may be detected by the systems and methods disclosed herein. Although not shown in
Referring to
At step 710, the method 700 includes activating, by one or more processors, a fan disposed within an ambient environment. In an aspect, the fan may be the fan 106 of
The ability to obtain such a wealth of chemical information from the exhaled breath of a viral infected individual also means that there are inevitable legal ramifications of the technology: right to privacy vis-à-vis confidentiality of medical health records. While exhaled breath samples are used for identification purposes by the health system, chemical biomarkers can contain personal information about each individual within the chemistry present, including gender and drug metabolites. Special protocols may be utilized to ensure that any medical information obtained from exhaled breath present in ambient air samples complies with all state and federal privacy laws related to health care.
The disclosed identification methodology could vastly aid in the identification of medical health issues, including bacterial and metabolic states. The current invasive techniques can be improved by gaining valuable chemical information using this non-invasive method. The data collected can also be collected and compared for future usage.
Although embodiments of the present application and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one of ordinary skill in the art will readily appreciate from the disclosure of the present invention, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present invention. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification.
The present application claims the benefit of U.S. Provisional Patent Application No. 63/012,886, filed Apr. 20, 2020 and titled “STANDOFF DETECTION OF DISEASE AND VIRUS METABOLITES USING ENVIRONMENT AIR CAPTURE COUPLED TO A TUNABLE MEMBRANE INLET MASS SPECTROMETER,” the contents of which are incorporated herein by reference in their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2021/052930 | 4/8/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63012886 | Apr 2020 | US |